Ryo Yoshimoto

1.8k total citations
43 papers, 1.4k citations indexed

About

Ryo Yoshimoto is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Ryo Yoshimoto has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Immunology and 6 papers in Surgery. Recurrent topics in Ryo Yoshimoto's work include Mast cells and histamine (8 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Ryo Yoshimoto is often cited by papers focused on Mast cells and histamine (8 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Ryo Yoshimoto collaborates with scholars based in Japan, United States and Spain. Ryo Yoshimoto's co-authors include Yoshiko Fujita, Tatsuya Sawamura, Akemi Kakino, Shin Iwamoto, Hiroshi Ozaki, Hideaki Karaki, Shigeru Tokita, Yasuhisa Miyamoto, Yuko Sato and Minori Mitsui‐Saito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Ryo Yoshimoto

42 papers receiving 1.3k citations

Peers

Ryo Yoshimoto
Ryo Yoshimoto
Citations per year, relative to Ryo Yoshimoto Ryo Yoshimoto (= 1×) peers Chang-Ping Hu

Countries citing papers authored by Ryo Yoshimoto

Since Specialization
Citations

This map shows the geographic impact of Ryo Yoshimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Yoshimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Yoshimoto more than expected).

Fields of papers citing papers by Ryo Yoshimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Yoshimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Yoshimoto. The network helps show where Ryo Yoshimoto may publish in the future.

Co-authorship network of co-authors of Ryo Yoshimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Yoshimoto. A scholar is included among the top collaborators of Ryo Yoshimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Yoshimoto. Ryo Yoshimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Kyohei, et al.. (2020). Discovery of a benzimidazole series as the first highly potent and selective ACSL1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 33. 127722–127722. 3 indexed citations
2.
Makino, Masaki, Ryo Yoshimoto, Masaki Ono, et al.. (2019). Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Scientific Reports. 9(1). 11862–11862. 142 indexed citations
3.
Kikuchi, Yukiko, Yoshihiro Kimura, Ryo Yoshimoto, et al.. (2015). Enhancement of Cellulose Degradation by Cattle Saliva. PLoS ONE. 10(9). e0138902–e0138902. 11 indexed citations
4.
Kikuchi, Yukiko, Ryo Yoshimoto, Yoshihiro Kanai, et al.. (2014). Promotion of crystalline cellulose degradation by expansins from Oryza sativa. Planta. 241(1). 83–93. 16 indexed citations
5.
Iwamoto, Shin, Yoshiko Fujita, Akemi Kakino, et al.. (2011). An Alternative Protein Standard to Measure Activity of LOX-1 Ligand Containing apoB (LAB) - Utilization of Anti-LOX-1 Single- Chain Antibody Fused to apoB Fragment. Journal of Atherosclerosis and Thrombosis. 18(9). 818–828. 12 indexed citations
6.
Yoshimoto, Ryo, Yoshiko Fujita, Akemi Kakino, et al.. (2011). The Discovery of LOX-1, its Ligands and Clinical Significance. Cardiovascular Drugs and Therapy. 25(5). 379–391. 125 indexed citations
7.
Fujita, Yoshiko, Akemi Kakino, Mariko Harada‐Shiba, et al.. (2010). C-Reactive Protein Uptake by Macrophage Cell Line via Class-A Scavenger Receptor. Clinical Chemistry. 56(3). 478–481. 17 indexed citations
8.
Nagumo, Akira, Yasuhisa Miyamoto, Hidefumi Kitazawa, et al.. (2010). Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6. European Journal of Pharmacology. 630(1-3). 34–41. 18 indexed citations
10.
Nagase, Tsuyoshi, Toshiyuki Takahashi, Akira Nagumo, et al.. (2009). Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors. Bioorganic & Medicinal Chemistry. 17(15). 5639–5647. 4 indexed citations
11.
Fujii, Kenji, Katsuya Ohbuchi, Katsumi Aragane, et al.. (2009). Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion. Biochemical and Biophysical Research Communications. 390(3). 377–381. 52 indexed citations
12.
Matsuda, Masao, et al.. (2009). Identification of a stable chemerin analog with potent activity toward ChemR23. Peptides. 30(8). 1529–1538. 36 indexed citations
13.
Takahashi, Toshiyuki, Tsuyoshi Nagase, Akira Nagumo, et al.. (2009). Synthesis and Evaluation of a Novel Indoledione Class of Long Chain Fatty Acid Elongase 6 (ELOVL6) Inhibitors. Journal of Medicinal Chemistry. 52(10). 3142–3145. 34 indexed citations
14.
Yoshimoto, Ryo, Akio Kanatani, & Shigeru Tokita. (2007). Distinctive role of central histamine H3 receptor in various orexigenic pathways. European Journal of Pharmacology. 579(1-3). 229–232. 10 indexed citations
15.
Ito, Sayaka, Ryo Yoshimoto, Yasuhisa Miyamoto, et al.. (2005). Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor. European Journal of Pharmacology. 529(1-3). 40–46. 15 indexed citations
16.
Miyamoto, Yasuhisa, Ryo Yoshimoto, Mariko Yumoto, et al.. (2004). Simultaneous fluorometric measurement of histamine and tele-methylhistamine levels in rodent brain by high-performance liquid chromatography. Analytical Biochemistry. 334(1). 89–96. 17 indexed citations
17.
Yoshimoto, Ryo, Katsuhito Takahashi, S. Taniguchi, et al.. (2000). Ca2+-Sensitization of Contraction in the h1 Calponin-Deficient Smooth Muscle. The Japanese Journal of Pharmacology. 84(4). 474–475. 8 indexed citations
18.
Yoshimoto, Ryo, Masatoshi Hori, Hiroshi Ozaki, & Hideaki Karaki. (2000). Proteolysis of Acidic Calponin by  -Calpain. The Journal of Biochemistry. 128(6). 1045–1049. 10 indexed citations
19.
Hori, Masatoshi, et al.. (1999). Actin depolymerizing action by marine toxin, Pectenotoxin-2. Folia Pharmacologica Japonica. 114(supplement). 225–229. 29 indexed citations
20.
Yoshimoto, Ryo, Minori Mitsui‐Saito, Hiroshi Ozaki, & Hideaki Karaki. (1998). Effects of adrenomedullin and calcitonin gene‐related peptide on contractions of the rat aorta and porcine coronary artery. British Journal of Pharmacology. 123(8). 1645–1654. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026